Overview
Higher EdPhase 4ketaminepsilocybinMDMAHiring
Emory University School of Medicine conducts psychedelic research in psychiatry and behavioral sciences.
Visit WebsiteAtlanta, GA
8
Clinical Trials
0
Open Roles
Open Positions
No open positions at this time
Research Areas
Clinical Pipeline(8)
Terminated·Phase 4·ketamine
Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients
KetamineOtolaryngeal Cancer
Not Yet Recruiting·Phase 2·ketamine
Electrophysiologic Mechanisms of Ketamine Antidepressant Response
KetamineEpilepsy
Recruiting·Early Phase 1·ketamine
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
KetamineMajor Depressive Disorder
Completed·Phase 1·psilocybin
Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain
PsilocybinHematopoietic and Lymphoid Cell Neoplasm
Recruiting·Phase 2·MDMA
MDMA-Assisted Massed Exposure Therapy for PTSD
3,4-Methylenedioxymethamphetamine (MDMA)Post Traumatic Stress Disorder
Completed·Phase 1·ketamine
Intranasal (NAS) Ketamine for Cancer Pain
Intranasal ketamineCancer
Enrolling by Invitation·Phase 2·MDMA
MDMA Plus Exposure Therapy for PTSD
MDMAPTSD
Recruiting·Phase 2·psilocybin
Psilocybin-Assisted Therapy
psilocybinPTSD